Showing results (371-380 of 1,271) with videos related to
Sort By:
Pageof 128
Psychopharmacology Bulletin|December 11, 2002
Dependence, dementia, cerebellar dysfunction, and myopathy in association with chronic isopropanol ingestionCindy Hanawalt-Squires, Theodore J AnfinsonPsychopharmacology Bulletin|December 11, 2002
Citalopram for the treatment of adolescent anxiety disorders: a pilot studyJefferson B Prince, Jeff Q Bostic, Michael Monuteaux, et al.Psychopharmacology Bulletin|January 1, 1996
Issues in polypharmacotherapy: focus on major depressionR L DufresnePsychopharmacology Bulletin|January 1, 1996
Comparison of therapeutic modalities for maniaJ G Small, M H Klapper, V Milstein, et al.Psychopharmacology Bulletin|January 1, 1996
Venlafaxine or bupropion responders but not nonresponders show baseline prefrontal and paralimbic hypometabolism compared with controlsJ T Little, T A Ketter, T A Kimbrell, et al.Psychopharmacology Bulletin|January 1, 1996
Paroxetine is a novel nitric oxide synthase inhibitorM S Finkel, F Laghrissi-Thode, B G Pollock, et al.Psychopharmacology Bulletin|January 1, 1996
A double-blind comparison of gepirone extended release, imipramine, and placebo in the treatment of outpatient major depressionA D FeigerPsychopharmacology Bulletin|January 1, 1996
Development and implementation of drug use evaluation (DUE) criteria for risperidone in an outpatient psychiatric settingJ C Shepski, M Z Wincor, M A Gutierrez, et al.Psychopharmacology Bulletin|January 1, 1996
Clinical and economic aspects of risperidone treatment in adults with mental retardation and behavioral disturbanceR S Lott, J M Kerrick, S A CohenPsychopharmacology Bulletin|January 1, 1995
The use of decision analysis in the pharmacoeconomic evaluation of an antidepressant: a cost-effectiveness study of nefazodoneS F Anton, D A RevickiPageof 128